Alteration of ribosome function upon 5-fluorouracil treatment favors cancer cell drug-tolerance

Nat Commun. 2022 Jan 10;13(1):173. doi: 10.1038/s41467-021-27847-8.

Abstract

Mechanisms of drug-tolerance remain poorly understood and have been linked to genomic but also to non-genomic processes. 5-fluorouracil (5-FU), the most widely used chemotherapy in oncology is associated with resistance. While prescribed as an inhibitor of DNA replication, 5-FU alters all RNA pathways. Here, we show that 5-FU treatment leads to the production of fluorinated ribosomes exhibiting altered translational activities. 5-FU is incorporated into ribosomal RNAs of mature ribosomes in cancer cell lines, colorectal xenografts, and human tumors. Fluorinated ribosomes appear to be functional, yet, they display a selective translational activity towards mRNAs depending on the nature of their 5'-untranslated region. As a result, we find that sustained translation of IGF-1R mRNA, which encodes one of the most potent cell survival effectors, promotes the survival of 5-FU-treated colorectal cancer cells. Altogether, our results demonstrate that "man-made" fluorinated ribosomes favor the drug-tolerant cellular phenotype by promoting translation of survival genes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimetabolites, Antineoplastic / pharmacology*
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / genetics
  • Colorectal Neoplasms / metabolism
  • Colorectal Neoplasms / pathology
  • DNA Replication
  • DNA, Neoplasm / genetics*
  • DNA, Neoplasm / metabolism
  • Drug Resistance, Neoplasm / genetics
  • Drug Tolerance / genetics*
  • Fluorouracil / pharmacology*
  • HCT116 Cells
  • Halogenation
  • Humans
  • Protein Biosynthesis / drug effects*
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • RNA, Ribosomal / genetics
  • RNA, Ribosomal / metabolism
  • Receptor, IGF Type 1 / agonists
  • Receptor, IGF Type 1 / genetics*
  • Receptor, IGF Type 1 / metabolism
  • Ribosomes / drug effects
  • Ribosomes / genetics
  • Ribosomes / metabolism
  • Xenograft Model Antitumor Assays

Substances

  • Antimetabolites, Antineoplastic
  • DNA, Neoplasm
  • RNA, Messenger
  • RNA, Ribosomal
  • Receptor, IGF Type 1
  • Fluorouracil